Earnings call transcript: Kraken Robotics Q4 2025 sees earnings miss By Investing.com

Kraken Robotics reported a Q4 2025 earnings miss, with EPS of $0 versus $0.0276 expected and revenue of CAD 28.39 million versus CAD 48.26 million expected, sending the stock down 0.59% pre-market. Offset against the weak quarter, full-year 2025 revenue rose 12.1% to CAD 102 million, gross profit increased 42% to CAD 63 million, and management guided 2026 revenue to CAD 165 million-CAD 175 million with adjusted EBITDA of CAD 40 million-CAD 50 million. The call also highlighted strong battery and SAS demand, expanding defense-related orders, and progress toward closing the Covelya acquisition.

Analysis

The market is likely misreading the quarter as a demand problem when the bigger issue is execution timing. The core business appears to be entering a capex-to-revenue conversion phase: capacity was added before utilization fully caught up, which can create near-term volatility in bookings, working capital, and quarterly revenue recognition even as the underlying order pipeline strengthens. That makes the current tape reaction more about visibility loss than fundamental impairment.

The first-order winners are the company’s direct competitors in naval sonar, subsea batteries, and inspection services, but the second-order winner may be the broader defense-electronics supply chain if Kraken’s backlog conversion delays push customers to multi-source or accelerate procurement from peers. The strategic combination with Covelya is more important than headline revenue because it should improve customer stickiness by bundling navigation, positioning, power, and sensing into fewer integrated procurements. That raises switching costs and can compress competitors’ sales cycles, especially for smaller point-solution vendors.

The key risk is that the market is currently paying for growth optionality, not current earnings, so any slippage in the second half can trigger a sharp de-rating from high-multiple levels. But the flip side is that guidance appears deliberately conservative relative to visible orders and the company’s stated seasonality; if even part of the pipeline converts early, the stock can re-rate quickly over the next 1-2 quarters. The most important catalyst is not the next reported EPS print but contract wins tied to geopolitical urgency and whether battery capacity ramps without operational bottlenecks.

Contrarian view: the selloff may be overdone because this is a low-liquidity growth name where a miss can force de-risking, yet the underlying thesis is becoming more diversified and less dependent on any single product line. The market is underestimating how much a stronger balance sheet plus added manufacturing capacity can shift Kraken from a lumpy niche supplier to a more reliable defense-platform provider over the next 12-24 months.

Key Decisions for Investors

• Buy KRKNF on weakness over the next 3-5 trading sessions with a 3-6 month horizon; risk/reward improves if the stock stabilizes above post-earnings low and the market refocuses on H2 order conversion rather than the quarter miss.
• Use a call spread in KRKNF for the next 3-6 months rather than outright stock; the setup is a classic volatility crush after an earnings disappointment, but upside can reprice quickly on contract announcements and Covelya close.
• Pair trade: long KRKNF / short a weaker subsea defense peer with less balance-sheet flexibility over 3-6 months; thesis is that Kraken’s liquidity and capacity expansion give it more operating leverage if defense urgency persists.
• If you want a lower-risk expression, wait for confirmation of Covelya close and the next order update before adding; the cleaner entry is after the market sees evidence that backlog is converting into revenue, not just commentary.
• For event-driven traders, own a small KRKNF position into potential deal-close headlines and TSX roadmap milestones; the stock can gap on M&A or listing news, but position sizing should reflect headline risk and high valuation sensitivity.